ASX:RAC - Long Shortz: Lung cancer trial edges closer to patient enrolment

Racura Oncology InvestorHub

Long Shortz: Lung cancer trial edges closer to patient enrolment

Host Tylah Tully sits down with Racura Oncology CEO Dr Daniel Tillett to discuss the company’s upcoming HARNESS-1 lung cancer trial. Watch the video here.

Your question will be sent privately to Racura Oncology. The company may choose to make this question public.

Start the conversation

Ask Racura Oncology a question about this update.

Share your feedback

Discover